A comparison of cardiovascular outcomes in postmenopausal women treated with aromatase inhibitors versus tamoxifen in breast cancer

被引：0
|
作者：
Fiorino, L. H.
Pitz, M.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-13-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-04
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bone Health in Postmenopausal Women with Breast Cancer Receiving Aromatase Inhibitors
    Zikan, Vit
    Zimovjanova, Martina
    Petruzelka, Lubos
    Pribylova, Jana
    Cabinakova, Michaela
    Raskova, Maria
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [32] New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women
    de Jong, PC
    Blijham, GH
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1999, 55 (02): : 50 - 58
  • [33] Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review
    Behan, Lucy Ann
    Amir, Eitan
    Casper, Robert F.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (03): : 342 - 350
  • [34] A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
    Thürlimann, B
    Keshaviah, A
    Coates, AS
    Mouridsen, H
    Mauriac, L
    Forbes, JF
    Paridaens, R
    Castiglione-Gertsch, M
    Gelber, RD
    Rabaglio, M
    Smith, I
    Wardly, A
    Price, KN
    Goldhirsch, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26): : 2747 - 2757
  • [35] Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
    Rossini, Alessandro
    Frigerio, Sofia
    Dozio, Elena
    Trevisan, Roberto
    Perseghin, Gianluca
    Corbetta, Sabrina
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [36] Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
    Stratton, Jamie
    Hu, Xin
    Soulos, Pamela R.
    Davidoff, Amy J.
    Pusztai, Lajos
    Gross, Cary P.
    Mougalian, Sarah S.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E505 - E515
  • [37] Tamoxifen versus aromatase inhibitors for the adjuvant treatment of breast cancer in older women: A feasibility study to examine differences in cognitive outcomes.
    Underwood, Emily Anne
    Jerzak, Katarzyna Joanna
    Pritchard, Kathleen I.
    Tierney, Mary Catherine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Comparison of cost-effectiveness of aromatase inhibitors letrozole, anastrozole or exemestane versus tamoxifen for early breast cancer in hormone receptor-positive postmenopausal women: Canadian perspective
    El Ouagari, K.
    Kamon, J.
    Kaura, S.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 210 - 211
  • [39] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [40] Arthralgia and Patient-Reported Outcomes in Postmenopausal Women with Early Breast Cancer Taking Aromatase Inhibitors
    Castel, Liana D.
    Hartmann, Katherine
    Chen, Heidi
    Mayer, Ingrid
    Boomershine, Chad
    McLellan, Sarah Elizabeth
    Cella, David
    [J]. JOURNAL OF WOMENS HEALTH, 2011, 20 (10) : 1390 - 1390
12345